GCT President, Dr. Jeffrey T. Apter, at CNS Summit 2018 in Florida, USA
GCT President, Dr. Jeffrey T. Apter attended CNS Summit 2018 in the The Boca Raton Resort & Club, Florida, USA. It is a great opportunity for pharma and biotech R&D leaders, the top tech companies, investigator sites, service companies, and the regulators from US FDA and EMA to recognize industry trends, lessons and experiences of the year. The Summit is known for its innovative content and format, building the community passionate about shaping the future, with a focus on collaboration, innovation, and technology.
Over the years GCT has gained a great experience of conducting clinical trial in CNS field in United States, Central-Eastern Europe and India. We are closely familiar with key opinion leaders in this therapeutic area, as well as experienced investigative sites and patient organizations and we will gladly apply this knowledge to assure the successful completion of your next planned clinical program.
Updated: November 6, 2018
Permanent link: https://2022.gctrials.com/posts/gct-president-dr-jeffrey-t-apter-at-cns-summit-2018-in-florida-usa/